►
From YouTube: Let's Talk: COVID-19 Vaccines for 5-11 Year Olds
Description
Local health experts and parents meet to discuss COVID-19 vaccinations for 5-11 year olds. Learn more at buncombeready.org
A
Good
evening,
everyone
and
thank
you
so
much
for
joining
us
tonight,
for
let's
talk
all
about
coveted
vaccinations
for
children
5
to
11.
before
we
get
started.
I
want
to
let
you
all
know
that
if
you'd
like
to
access
this
presentation
in
spanish,
you
can
click
the
zoom
the
button
on
your
zoom
invitation
that
will
interpret
it
into
spanish
for
you
or
you
can
access
the
presentation
via
the
health
and
human
services
page,
which
is
in
spanish,
and
then
the
english
version
is
on
the
buncombe
county
page.
A
What
facebook
page,
I'm
megan
williams,
a
bunch
of
county
resident
and
the
mother
of
four
children
who
attend
buncombe
county
schools,
schools
in
buncombe
county,
I'm
happy
to
be
here
to
talk
with
some
of
our
local
experts
about
the
pfizerkovit19
vaccine
that
was
recently
given
emergency
use
authorization
for
the
5-11
age
group,
in
addition
to
being
offered
in
spanish,
we're
also
offering
american
sign
language
interpretation
services.
Tonight.
A
A
B
C
D
I
think
I'm
up
next
right
hi.
This
is
stacey
turpin
sauders.
I
am
public
health
director
for
buncombe
county
and
also
mom
of
two
children,
one
who
has
already
been
vaccinated
and
one
who
is
now
eligible
and
looking
forward
to
talking
to
you
all
about
vaccines.
Tonight.
A
Great,
thank
you
all
so
much
for
joining
us
tonight.
So
we'll
go
ahead
and
get
started.
The
first
question
I'm
going
to
throw
to
stacy
stacy.
Can
you
share
some
information
about
how
the
vaccine
for
this
5
to
11
age
group
is
different
than
the
vaccines
that
are
currently
available
for
people
over
age,
12.
D
Thanks
for
the
question,
and
so
I
think
what
I'll
do
first
is
just
sort
of
start
with
a
recap
of
what
vaccine
is
available,
because
now
we
have
lots
of
different
vaccine
and
different
age
groups
that
are
eligible
and
so
just
to
remind
folks
that
we
have
three
different
different
vaccines
and
that's
the
the
pfizer,
the
moderna
and
then
the
j
and
j
and
all
three
are
for
all
three
of
them
are
18
our
18
year
olds
and
older
are
all
eligible
for
those
for
our
adult
population
and
then,
when
we
get
into
12
to
17
year
olds,
only
the
pfizer
and
then
also
now
with
our
recent
eligibility,
our
five
to
11
year
olds,
only
the
pfizer
and
so
to
answer
your
question.
D
D
Sometimes
folks
will
say:
mrna
vaccine
teaches
our
cells
how
to
make
a
protein
that
will
trigger
our
immune
response
inside
our
bodies,
and
you
know,
like
all
vaccines,
the
messenger
rna
vaccines
benefit
people
who
get
vaccinated
by
giving
them
protection
against
actual
illness
without
actually
you
know
without
risking
getting
the
illness
where
consequences
of
getting
sick
could
could
be
very,
very
diverse,
specific
to
the
covet
19
vaccine
available
for
children.
D
D
This
one-third
the
amount
of
the
adult
dose
that
we
see
with
the
pfizer
vaccine,
and
you
know
that
lower
dose,
minimizes
side
effects,
but
still
prompts
that
strong
immune
response
and
and
for
this
particular
population
we
think
about
children,
children,
you
know
in
general
have
robust
immune
response.
You
know,
unlike
as
we
get
older,
sometimes
our
immune
system
doesn't
quite
elicit
the
same
type
of
or
the
same,
robust
immune
response.
D
So
a
little
can
go
a
long
way
for
our
children
versus
older
populations,
where
we
need
that
higher
dose
to
get
that
robust
immune
response-
and
I
guess
I'll
also
just
say
that
you
know
for
the
the
pfizer
vaccine
for
children
5
to
11
and
for
the
the
adult
version.
It
has
the
same
ingredient
same
active
ingredients
as
the
vaccine
given
to
adults
and
adolescents.
D
What
we
do
or
what
you
will
see
are
smaller
needles,
obviously
smaller
bodies,
so
smaller
needles
designed
specifically
for
this
particular
population
and
just
like
the
adult
version,
you
know
there
will
be
the
need
for
a
second
dose.
A
All
right,
thank
you,
so
much
so
if
kids
are
somewhat
less
likely
to
get
severely
ill
from
covid,
why
do
they
need
to
get
the
coven
19
vaccine.
A
This
one
to
start
with
at
april,
please.
E
Yeah,
so
I
think
there
are
several
reasons
that
it's
important
for
this
age
group
to
get
vaccinated,
so
the
first
is,
although
they
may
be
less
likely
to
get
seriously
ill
with
covid,
they
can
become
severely
ill.
There
certainly
are
children
who
have
been
hospitalized
in
the
icu
and
unfortunately
have
died
from
covid.
So
it's
still
a
possibility.
E
I
think
we
also,
you
know,
I
think
stacy
alluded
to
sort
of
risk
versus
benefit,
and
we
know
that
there
are
risks
to
contracting
covid,
whereas
there
are
very
little
risks
from
the
vaccine.
So
there's
always
sort
of
that
risk
benefit
analysis.
E
E
So
we
would
want
to
prevent
that,
if
possible
and
again,
although
they're
less
likely
than
adults
to
experience
this
particular
complication,
they
can
get
long
covered,
which
is
where
they
can
have
those
lingering
symptoms.
After
a
coveted
infection
for
a
long
time,
anything
ranging
from
fatigue
to
respiratory
issues
so
anytime
we
can
prevent
illness.
I
think
that
we
should,
and
then
you
know
two
just
like
with
any
age
group
vaccinating
you
know
kids
ages,
5
to
11
protects
them,
but
it
also
helps
to
protect
our
larger
community.
E
B
Megan,
do
you
mind
if
I
add
to
that
a
little
bit
go
ahead.
You
know,
as
we
think
about
it
too.
I
come
from
them.
I
come
from
a
family
practice
background,
but
I
work
in
a
behavioral
health
organization,
and
I
also
just
note
too,
that
the
impact
that
this
has
had
on
all
of
our
lives
with
the
stress
and
the
anxiety,
it's
caused
the
depression
that
people
are
suffering
and
we
know
it's
even
had
more
effect
on
anybody,
children
or
adults
who
had
something
in
a
pre-existing
situation.
They
already
had
adhd.
C
B
There
in
the
school
is
one
of
our
our
first
steps
for
their
mental
health.
In
that
respect,
and
also
a
lot
of
the
services
they're
receiving
are
in
those
schools
and
getting
vaccinated
is
just
a
really
big
key
to
to
keeping
them
at
school
and
not
having
all
those
days
that
they
need
to
be
absent
or-
and
I
I
commend
the
teachers
who
have
done
the
remote
learning
and
the
administrators
who
figured
it
out.
But
it's
not
it's
not
the
same.
C
And
megan
can
I
say
something
as
well:
yeah
all
right
just
from
the
primary
care
medical
side.
I'll
just
say
that
I
think
for
some
of
us
that
you
may
be
getting
your
your
kids
ready
for
dinner.
You
might
be
getting
picking
them
up
from
from
after
school
programs.
So
I'll
give
you
the
cliff
notes
edition,
but,
but
I
think
it's
safe
to
say
and
we'll
prove
this
a
little
bit
later
on
that
that
that
number
one
covet
is
prevalent.
C
I
think
sometimes
we
forget
that
that
we've
had
6.4,
probably
more
than
that
at
this
point
million
children
affected
with
a
positive
test,
maybe
they're
not
that
serious,
but
1.3
million
of
those
have
been
even
since
the
beginning
of
school.
So
the
numbers
are
going
up.
You
know
it
could
be
even
24
26
of
the
total
cases
and
then
also.
I
think
that
the
again
the
cliff
notes
edition
is
that
I
think
covet
has
bad
outcomes.
You
know
we
forget
about
that
mortality.
Isn't
the
only
outcome
problem?
C
Yes,
there's
only
like
point
two
percent
of
the
covet
associated
deaths
or
children,
but
it's
still
higher
than
than
a
lot
of
other
reasons
why
kids
die.
In
fact,
I
think
it's
now
eight
on
the
list
number
eight
in
terms
of
pediatric
deaths
for
a
hundred
thousand
kids
over
the
last
year,
and-
and
so
I
think
that
there
is
that,
but
also
that
you
have
hospitalizations
like
we
were
mentioning
the
covert
associated
long-term
effects,
and
I
think
that
probably
one
of
the
more
important
things
is
that
we
have
a
vaccine.
C
That's
that's
safe
and
we'll
talk
about
that,
but
that's
safe,
that's
effective,
but
it's
not
going
to
be
effective
forever
and
one
of
the
problems
that
I
think
about
is
that
coronavirus
love
to
mutate.
That's
why
we
have
colds,
and
we
have
this
window
of
time
where
we
have
a
vaccine,
that's
effective!
That
does
a
good
job
that
I
will
argue
that
it's
safe
and-
and
we
have
this
opportunity
with
a
pediatric
population
that
sometimes
sees
the
worst
outcomes
of
cobit.
C
That
misc
that
april
was
mentioning
is,
is
something
that
you
see
peaking
in
the
five
to
eleven
age.
Demographic,
in
fact,
that
the
multi-system
in
florida,
inflammatory
syndrome,
is
peaks
at
age
nine,
and
these
are
kids
who
have
not
had
the
opportunity
to
have
the
vaccine
up
until
this
point.
So
so
I
think
we
have
this
window
of
time
where
I
think
that
I
think
that
now
is
is
a
good
time
to
consider,
weigh
it
for
your
family,
and
I
think
it's
a
wonderful
vaccine
at
preventing
some
serious
outcome
problems.
A
Thank
you
for
all
of
that
information
and
so
regarding
side
effects,
because
we've
heard,
or
you
know,
we've
if
we've
gotten
the
vaccine
ourselves
or
if
we've
you
know
heard
about
others,
we
may
have
experienced
some
side
effects
with
that
and
I
can
understand
why
some
people
might
be
nervous
about
that
possibility
for
their
kids.
So
what
should
we
expect
in
terms
of
side
effects
for
kids
and
should
we
be
concerned
about
them
and
I'll
put
that
to
you,
dr
o'donnell?
If
you
don't
mind.
C
Yeah
yeah
thanks
april.
This
is
a
weighted
question,
because
there's
a
lot
of
side
effects
that
people
will
see
in
here
just
from
regular
vaccines
and
from
personal
accounts,
but
but
first
I'll
just
talk
about
the
study.
The
study
was
done
on
on.
C
Initially
it
was,
it
was
done
on
2200,
kids,
2268,
kids
and,
and
they
were
followed
for
a
good
two
months.
1508
1518
got
the
vaccine,
they
added
another
2
300
children
to
that
number
to
bolster
some
of
their
numbers,
and
so
a
total
of
of
maybe
4
600
children
got
enrolled
in
the
study.
3000
plus
were
were
vaccinated
with
the
pfizer
vaccine
and
and
the
first
group
was
followed
for
two
months.
The
second
group
is
followed
for
for
two
to
four
weeks
up
at
this
point.
C
It's
it's
a
little
bit
longer
now
and-
and
people
always
ask
me,
is
that
enough
time
to
see
side
effects
and
the
majority
of
side
effects
that
we
see,
including
even
in
the
chickenpox
vaccines
and
the
measles
vaccines?
C
The
majority
of
side
effects
you'll
see
in
the
first
four
weeks
now,
there's
some
other
ones
that
we
see
down
the
road
and
we'll
talk
about
those
a
little
bit
in
terms
of
inflammation,
but
but
out
of
that,
the
the
effect
of
that
vaccine
in
terms
of
how
effective
it
was
in
terms
of
creating
antibody
responses
and
body
numbers
was
somewhere
in
the
in
the
realm
of
90.7
percent,
effective
in
preventing
covet
disease
and,
and
probably
more
importantly,
it
was
effective
against
delta,
of
course,
and
and
what
we
needed
to
prove
was
that
it
had
something
called
the
immunobridging
which
was
similar
to
the
vaccine.
C
That
was
done
in
the
12
to
17
year
old
year,
old
age
range,
as
well
as
in
the
adults,
and
so
as
far
as
we
can
tell
from
these
studies,
it
actually
shows
a
really
good
effect
at
preventing
severe
outcomes
from
covet.
It's
not
going
to
prevent
you
from
catching
covet,
but
it's
going
to
prevent
the
severe
outcomes
that
we
see
now
to
answer.
C
Your
question
specifically
megan
is:
is
that
you
do
see
side
effects
and
there's
the
common
side
effects
where
you
get
muscle,
pain
and
swelling
about
39
of
kids
got
fatigue,
another
28
percent
got
headaches
and
then
there's
a
10
to
15
percent
that
got
my
algaes,
which
is
muscle
aches.
You
got
joint
pains
and
in
fact
we
actually
saw
lymphadenopathy.
You
see
some
big
lymph
nodes
in
a
decent
percentage
of
these
children
as
well,
and
we
consider
that
to
be
pretty
normal
findings
after
a
vaccine.
C
It's
a
good
immune
response,
the
other
things
which
which
just
to
show
you
how
comprehensive
these
studies
have
to
be.
Is
that
apparently
other
serious
side
effects
is?
Is
one
child
swallowed,
a
penny?
Another
person
broke
a
bone
and
another
child
had
an
infection
of
a
joint
and
those
are
obviously
unrelated
to
the
vaccine
itself.
But
we
have
to
report
everything
that
happens
in
the
time
period
after
you
get
the
vaccines.
C
Probably
the
more
question.
The
more
important
question
megan
is
is
is:
should
we
be
concerned
about
those
side
effects
and
maybe
even
the
side
effects
that
we
don't
know
about,
but
but
I'd
like
to
I'll,
probably
change
the
dialogue
a
little
bit
in
the
sense
that
I'm
not
comparing
the
vaccine
side
effects
versus
nothing,
I'm
usually
when
I'm
when
I'm
talking
to
people.
I
compare
the
vaccine
side
effects
versus
covet
disease
itself
and
the
side
effects
that
we
get
and
we've
already
talked
about
some
of
the
bad
outcomes
from
it.
C
But
but
I'll
give
you
one
example,
I
think
is
probably
pertinent
and
that's
specifically
myocarditis
and
pericarditis,
and
and
that's
inflammation
of
the
heart,
where
you
get
inflammation
of
the
muscle
cells
of
the
heart
itself
or
the
sac
around
your
heart,
and
we
know
that
children
get
this.
They
get
this
from
viral
infections
and
they
should.
I
should
separate
this
there's
a
virally
induced
myocarditis,
where
you
get
specifically
enteroviruses.
C
There
is
some
secondary
inflammation
and
you
do
see
some
side
effects
from
that.
But
it's
still
it's
less
intense.
You
typically
don't
see
the
death
rate
that
you
see
with
a
viral
infection
of
your
heart,
and
so
what
we
see
with
that
is
a
baseline,
a
baseline
is
that
children
typically
will
have.
Maybe
nine
per
hundred
thousand
kids
in
a
typical
year
will
get
virally
induced
myocarditis
with
the
vaccine.
C
The
numbers
are
slightly
different,
but
there
are
62
cases
this
in
the
12
to
17
year
old
range,
62
cases
of
vaccine-induced,
myocarditis
or
pericarditis
per
million
kids,
who
got
two
doses
of
the
vaccine.
Now
that
is
actually
the
same
or
less
than
the
background
rate
of
myocarditis
that
kids
get
on
a
regular
basis.
C
But
it's
16
times
that
rate,
so
a
child
diagnosed
with
covid
has
a
case
rate
of
of
myocarditis
of
150
per
100,
000
children,
it's
dramatically
larger
and
it's
somewhat
intuitive
in
the
sense
that
if
I
give
you
some
spike
protein
in
your
arm-
and
you
form
an
immune
response
to
that
and
that
immune
response
gives
you
some
inflammation
in
your
in
your
chest,
which
typically
is
short-lived
less
than
five
to
seven
days.
Kids,
no
one's
died
from
that
by
the
way.
So
so
we
have
reports
we're
actually
following
up
on
it.
C
There's
nih
studies
but
nobody's
actually
died
from
that
myocarditis.
But
it's
supportive
care.
You
get
better
and
kids
recover
from
that,
but
if
I
see
that
compared
to
the
same
exact
condition,
but
but
with
a
much
serious,
much
more
serious
outcome
with
longer
hospitalizations
due
to
the
covet
itself,
I
still
think
that
the
the
benefit
of
a
vaccine,
in
terms
of
both
avoiding
the
long-term
outcomes
of
kovic,
but
also
even
the
myocarditis
itself.
It's
it's
a
moot
point.
The
the
evidence
supports
getting
the
vaccine
to
minimize
your
chance
of
even
the
myocarditis.
A
B
Sure
so
I
think
when
we,
when
people
commonly
refer
to
natural
immunity,
what
they're
talking
about
is
if
they
have
been
infected
with
the
virus.
So
at
this
point,
we're
talking
about
covid,
so
they've
been
infected
with
covin
and
created
a
natural
immunity
versus
when
we
talk
about
a
vaccine-induced
immunity
when
the
vaccine
has
been
injected
and
it's
and
it
has
given
you
that
immunity
from
there.
B
I
I
don't
particularly
like
calling
it
natural
immunity,
because
really
both
of
them
are
your
body's
natural
reaction
to
something
that
it's
been
exposed
to
and
that
it
like,
in
instance,
of
the
vaccine
and
an
instance
of
covet.
It's
it's
that
spike
protein,
and
so
your
body
says
this
is
foreign
and
it
creates
a
natural
immune
response.
B
So
in
one
sense
I
think
that
it's
not
probably,
I
think
it
probably
just
sheds
a
light
that
makes
us
think
that
we're
in
somehow
something
different
is
happening.
Once
we
get
the
vaccine
that
spike
protein
that
we
are
exposed
to
or
through
that
mrna
that
that
is
gone
within
at
max
72
hours
and
what
you
have
left
is
your
bodies,
and
that
has
the
antibodies
that
your
body
has
created
to
to
then
address
covert
immediately
if
your
body
is
exposed
to
it
later.
B
So
I
think
that's
one
thing
to
start
with
is
just
that.
I
think
that
creates
some
some
confusion
and
then
I
think
that
the
other,
the
other
thing
about
the
difference
in
those
in
the
and
the
exposure
like
where
where's
the
risk
and
the
vaccine,
and
so
we've
talked
about
some
of
the
things
that
we
think
are
risks
and
side
effects
of
vaccine
here
tonight.
B
But
then
there's
also
the
the
risk
of
being
exposed
to
the
to
the
virus
to
provide
and
the
risk
then
of
severe
illness
or
death,
and
it's
it's
small
in
children,
but
it's
real
and,
as
I
always
say
to
my
patients,
you
know
I
I
tell
I
tell
them
a
risk
benefit
analysis.
I
say:
maybe
you
know
the
risk
of
you
getting.
B
This
is
twelve
percent,
but
if
you're
the
person
who
gets
it,
it's
a
hundred
percent
you
and
that's
true
with
any
of
the
side
effects
than
any
of
the
exposure
that
we
have
to
this
virus.
And
so
we
have
to
look
at
that
and
it
and
so
there's
a
real
risk
of
severe
disease.
And
that's
precisely
what
the
vaccine
was
developed
to
do
is
to
prevent
the
severe
disease
and
to
prevent
death
from
from
the
exposure
to
the
virus.
B
A
Follow-Up
to
that,
so
how
does
the
vaccine
then
play
into
transmission
of
coba
19?
Is
there?
Does
it
provide
some
protection
against
transmit,
transmitting
it
to
others?.
B
It
does
and
what-
and
these
are
difficult
numbers
to
give
a
solid
number
in
the
overall
scheme
of
things
we
are,
as
we
know,
or
early
in
into
this
virus.
It's
only
been
around
you
know
for
this
short
time,
and
so
the
things
that
we're
doing,
I
think
that
they're
they're,
all
all
of
the
information
that
we're
getting,
has
been
based
on
science
and
we're
exploring
it
in
a
very
sound
and
scientific
way.
But
of
course,
our
knowledge
base
is
growing
as
we
move
forward
with
this
we're
not
in
a
lab.
B
So
when
we,
what
we
know
about
it,
though,
is
that,
yes,
if
you
get
infected
with
the
virus
after
you've
been
vaccinated,
then
we
do
know
that
you
can
transmit
the
disease,
but
it
appears
as
though
the
best
that
we
can
with
our
knowledge
at
this
point,
but
it's
probably
with
this
variant,
probably
for
about
six
days
or
so
you
can
transmit
the
disease
after
you're
infected
and
you've
been
vaccinated
versus
if
you're
exposed
to
covid
and
become
ill
from
that.
B
From
a
natural
exposure
to
the
virus,
it's
probably
closer
to
10
days,
so
it
does
diminish
the
amount
of
transmission
that
you
can
have.
The
other
thing
to
note
is
the
vaccine
prevents
disease
in
a
lot
of
people,
and
so
noting
that
that
means
that
there
are
fewer
people
that
you
are
exposing
it
to.
So
we
have
to
take
that
number
into
account
too,
that
there
are
fewer
fewer
people
who
are
vaccinated,
who
are
getting
it,
but
if
they
do
on
average,
we
think
they
probably
are
able
to
transmit
it
for
about
40.
A
Okay,
thanks
for
that,
so
what
about
kids
that
have
already
had
covid?
Do
those
kids
still
need
to
get
vaccinated?
What
would
be
the
benefit
of
that.
B
And
that's
true
across
all
of
our
age
groups
that
they're?
Yes,
that's
the
short
answer.
Yes,
we
you
should
be
vaccinated,
even
if
you
have
been
infected
by
covid,
but
it's
also
not
a
cut
and
dried
answer.
It
really
depends
on.
First
of
all,
when
your
infection
was,
we
certainly
don't
want
somebody
coming
out
who
should
be
in
isolation
and
getting
a
vaccination.
B
On
average,
I
would
say
that
the
general
rule
of
thumb
is
within
90
days
of
an
infection.
You
should
be
vaccinated
and
that's
been
the
general
rule
of
thumb
from
the
beginning,
but
I
think
that
each
individual
case
is
playing
out
a
little
different
in
that
respect.
A
C
Can
I
comment
too:
oh
yeah
yeah.
I
just
wanted
to
say
that
the
the
the
problem
with
the
coco
disease,
when
you
actually
contract
the
disease,
there's
such
a
variability
in
the
severity.
How
much
you
you
got
inoculated
by
so,
for
example,
if
you
have
a,
I
have
several
children
who
have
had
really
what
I
would
consider
be.
A
high
rate
of
infection
got
very
sick
with
it
high
fevers.
C
So
when
we
get
this
data
on
how
long
you
maintain
immune
memory,
how
long
their
antibody
responses,
alas,
for
it
seems
like
it's
widely
variable,
in
fact
not
not
to
be
defeatist,
but
you
know:
there's
there's
reports
that
the
vaccine
works
better
than
natural
immunity
and
I'm
not
going
to
go
into
that
very
much
because
I
because
the
problem
with
that
is
that
there
is
no
way
of
quantifying
your
natural
immunity
or
what
people
get
from
catching
the
disease
in
schools
or
at
home,
because
you
just
don't
know
how
much
they
catch.
C
C
How
long
should
should
we
consider
them
to
be
immune
for,
and
when
should
we
give
them
a
covet
vaccine
and
and
for
cdc
purposes
they
have
to
make
one
rule
fits
all,
but
I'm
just
going
to
say
that
that
I
usually
use
a
lot
of
a
lot
of
clinical
judgment
and
just
figure
out
how
sick
you
are,
and
if
you
really
didn't
get
a
severe
version
of
covid
or
you
tested
positive
and
you
didn't
know
you
had
it.
C
I
really
can't
tell
you
that
your
immune
memory
is
going
to
go
very
long,
and
so
so
those
are
the
kids
that
I
I
consider
actually
vaccinating
on
time,
meaning
that
within
the
90
days,
kids,
who
are
really
sick
or
who
get
a
big
response
to
the
first
vaccine,
we
can
always
tailor
that,
depending
upon
your
own
immune
response,
thanks.
A
So
what
I'm
hearing
you
say
is
the
immune.
The
immune
system
is
incredibly
complex
and
that
it
varies
right,
basically
right,
okay,
so
one
of
the
other
concerns
that
I
have
heard
from
other
parents
about
the
vaccine
is
whether
it
has
long-term
health
impacts
on
their
children.
A
I
know
you've
touched
on
this
already,
but
is
there
anything
else
you
wanted
to
say
about
about
this
particular
concern.
A
C
It
was,
I
think
I
was
up
for
that.
First
and
yeah
I'd
be
lying.
If
I
said
we
know
long-term
effects,
I
mean,
there's
there's
no
real
way.
The
studies
that
we
have
are
all
based
off
of
children.
Getting
this
within
the
last.
You
know
two
or
three
months,
and
so,
and
so
I
can't
tell
you
that
that
we
have
no
long-term
effects,
I'm
still
going
to
change
that
dialogue
a
little
bit,
and
I
say
that
we
also
don't
know
the
long-term
effects
of
having
covet.
C
So
we
still,
we
still
see
plenty
of
long
covety
symptoms
we
still
see
and-
and
I
should
mention
this
covered
children-
children's
form
is
typically
seven
to
eight
percent
of
kids,
who
get
a
severe
case
of
covid,
we'll
end
up
with
some
insomnia,
some
forgetfulness,
what
we
call
the
fog
and
even
have
long-term
headaches
for
more
than
four
to
five
weeks.
We
don't
even
know
if
that's
going
to
be
long-standing.
C
We
hope
that
it
won't
be
so
so
I
think
that
I
think
that
the
code
itself
has
a
potential
for
some
long-term
effects
and
I
think
we
already
got
some
education
on
on
how
the
vaccine
works,
and
so,
if
I
have
a
certain
immune
response
to
spike
proteins
that
I
have
a
defined
amount
that
I
put
in
my
arm,
then
any
any
serious
disease
that
you
have,
that
has
maybe
millions
of
times
that
amount
of
spike
protein
and
such
in
this
similar
immune
response
will
probably
cause
the
same.
C
If
not
worse,
you
know
vaccine
outcomes,
but
but
I
will
mention
that
that
some
of
the
things
that
we've
been
looking
at
you
know
from
the
medicine
side
was
that,
of
course,
I'll
debunk.
Some
of
the
things
that
you
know
that,
of
course,
we
got
worried
about
microchips,
I'm
not
too
worried
about
microchips
or
magnetic
potential.
You
know,
there's
no
live
virus
in
the
vaccine,
so
you're
not
going
to
catch
covet
from
the
vaccine.
C
One
of
the
main
ones
that
I've
seen
or
I've
heard
about
is
menstrual
menstrual
irregularities,
so
menstrual
cycle
changes,
and
maybe
even
questions
about
fertilization
and
infertility
risks,
and
so
I'm
not
going
to
say
that
we
have
a
plethora
of
data
on
that.
We
don't.
We
don't
have
a
ton
of
information,
but
I
will
say
that
that
we
have
a
couple
of
studies
that
have
already
started
addressing
this.
So
the
first
one
is
is,
is
done
well,
both
of
them
have
done
within
the
last
12
months.
C
In
fact,
they
finished
up
in
august
and
and
the
best
way
of
us
being
able
to
figure
out
if
it
really
does
affect
fertility,
is
looking
at
a
controlled
environment.
So
the
the
only
way
we
can
really
do
that
is
is
typically
to
take
to
take
in
vitro
fertilization.
C
Where
you
take
an
egg,
you
fertilize
it
outside
of
the
womb
and
you
implant
it
in
the
in
the
uterus
itself
and
see
if
you
see
what
the
success
rates
of
of
having
a
viable
fetus
after
that
and
and
out
of
the
out
of
the
women
in
two
different
studies
that
had
that
done.
People
who
had
the
cova
vaccine
versus
people
who
did
not
have
the
cova
vaccine
achieved
the
same
exact
fertility
rates,
the
same
exact
sur
success
rates
and,
and
that
was
done
both
with
people
that
we
weren't
sure
of
their
covet
status.
C
And
then
they
got
the
copa,
vaccine
and
people
who
then
were
teared
out
into
having
covid
having
a
coveted
vaccine
and
then
and
then
adult
woman
who
had
neither-
and
it
still
seemed
in
both
of
those
studies
to
to
maintain
exactly
the
same
fertility
rates.
Unfortunately,
with
menstrual
irregularities,
there's
no
way
of
knowing
what
will
cause
those
menstrual
irregularities.
There's
a
lot
of
stress
if
you
get
a
vaccine.
There's
also
stress
about
what
you
did
to
your
body.
And
so
I
can't.
C
I
can't
tell
you
that
we
know
why
you
have
menstrual
irregularities
and
there's
a
lot
of
anecdotal
reports.
I
can
say
that
the
nih
is
looking
into
that
right
now,
which
is
all
the
nasa
national
institutes
of
health
is,
is
looking
into
that
to
see
if
there
is
something
that
they
can
find
as
a
reason
for
that.
C
But
we
have
no
answers
for
that,
and
and
one
other
study,
that
I'll
mention
in
terms
of
fertility
is
that
men
who
got
the
covet
vaccine
in
in
a
recent
study
as
well
showed
that
they
actually
have
the
same
exact
sperm
rates,
viable
sperm.
C
If
you
had
the
copa
vaccine,
if
you
had
the
copic
vaccine,
you
could
check
sperm
before
you
got
it
and
then
afterwards,
and
then
also
people
who
did
not
get
the
covered
vaccine
versus
people
who
did,
and
so
we've
seen
the
same
sperm
counts
and
viable
sperm,
regardless
of
the
covid
vaccine,
which
for
me
answers
a
little
bit
of
a
question
which
is,
which
is
that
I
I
don't
know
why.
We
have
the
menstrual
irregular
reports.
But
I
do
know
that
it
one
way
or
another
doesn't
appear
to
affect
fertility
in
any
way.
C
And
the
last
thing
is
that
I
will
say
that
if
you
have
vaccines,
you
know
like
if
you
have
vaccine
side
effects
that
are
related
to
the
child's
immune
system
in
the
response
to
a
vaccine.
And
then
and
then
you
have
this
uncontrolled
amount
of
vaccine
or
amount
of
virus
that
you
catch
and
the
same.
Inflammatory
response
that
I
still
argue
that
a
vaccine
with
a
defined
amount
of
immune
response
is
far
better
than
getting
coveted
itself.
A
Thank
you
does
anyone
else
have
anything
to
add
to
that
particular
question:
you
cover
that
really
well,
dr
o'donnell,
thanks
all
right
so
another
another
thing
I've
heard
from
from
others
is
some
version
of
cobia
19.
Isn't
that
serious
or
we
need
to
learn
to
live
with
it
like
the
flu?
A
Is
this
true
and
what
is
the
latest
information
show
us
about
code
in
our
community
and
I'll
direct
this
one
towards
stacy
saunders.
D
D
We've
experienced,
I
think,
at
the
the
last
time
I
checked
almost
47
million
cases
in
the
united
states
and
and
well
over
we're
getting
close
to
800
000
of
our
friends
and
family
and
neighbors
here
in
the
in
the
u.s
that
have
died
of
cover-related
illness,
and
you
know,
and
if
I
I
also
think
in
the
in
the
previous
year,
we
saw
kevin
19,
I
believe,
was
the
third
most
common
cause
of
death
in
the
us.
You
know
only
to
be.
D
You
know
it's
only
behind
those
really
heavy
hitters
like
heart
disease
and
cancer.
D
So
that's
a
pretty
serious
title
to
have
for
an
infectious
disease
and
and
certainly
makes
it
stand
out
from
from
seasonal
flu
in
a
lot
of
ways,
and
you
know
it,
I
also
you
know
when
you
know
I've
been
in
the
pandemic
response
now,
for
I
think
20
months-
and
I
remember
the
very
you
know
early
days
when
we
were
first
identifying
folks
who
had
coveted
illness
and-
and
you
know
those
are
those
symptoms
and
and
learning
about
the
different
symptoms
that
and
and
how
hard
it
was
hitting
people
you
know
in
the
early
days
we
knew
each
and
every
one
of
those
folks
and-
and
I
remember
the
first
death
that
my
community
at
that
time,
experienced
and
and
feeling
sort
of
the
gravity
of
what
this
could
be,
and
here
in
you
know,
in
buncombe
county.
D
You
know
we're
still
in
a
time
of
very
high
transmission
in
our
community,
and
you
know
that
means
that
coca-19,
while
we're
seeing
cases
decline
right
now,
it's
circulating.
D
You
know
among
us
in
really
large
amounts
and
predominantly
the
you
know
it
is
the
predominant
respiratory
illness
right
now
that
is,
is
circulating,
and
so
you
know,
while,
while
encouraging
those
case
case
rates
are
decreasing
and
that's
very
encouraging
and
nobody,
no
one's,
probably
more
excited
about
that
than
than
I
am
to
see.
Those
case
case
rates
decrease.
D
We
still
have
quite
a
bit
of
transmission
and
spread
of
covet
19,
not
just
in
our
community
but
in
in
our
entire
state,
and
you
know
I
I
consistently
say
that
pathogens
do
not
know
these
man-made
constructs
of
a
of
a
county
line,
and
so
you
know
we're
we're
just
you
know
as
vulnerable
as
as
the
transmission
rates
in
our
neighbors
counties,
as
well
as
we
travel
back
and
forth,
and
sometimes
folks
work
in
one
county
and
live
in
another,
and
you
know
I'd
be
remiss
to
sort
of
say
too
that
we,
I
still
think
about
covet
in
a
really
serious
way,
is
we're
about
to.
D
You
know
embark
on
several
holidays
in
a
row
and
what
we've
known
over
the
last
20
months
with
covid
is
that
we
do
see
an
increase
in
an
often
a
surge
in
cases
after
major
holidays,
where
folks
tend
to
get
together
with
family
and
friends,
and
so
I
think,
I'm
you
know
we're
really
hopeful
that
with
vaccination
rates
beginning
to
get
higher
and
that
we
will
not
see
those
mountainous
peaks
of
cases
that
we
saw
last
year.
D
But
nonetheless,
you
know,
we
anticipate
that
we'll
see
an
increase
in
cases
as
groups
of
people
celebrate
together,
and
you
know
that
that
that
is
our
reality
right
now
that
we
still
we're
entering
a
time
of
the
year
when
group
gatherings
are
quite
high
and
we're
entering
that
time
and
space
at
a
really
high
level
of
transmission.
D
So
it
can
be
a
it's
a
fairly
precarious
place
for
me
to
be
thinking
about
right
now,
but
to
your
question
about
you
know
why.
I
hear
that
too,
a
lot
about
shouldn't.
We
just
you
know,
go
along
with
our
lives
and
live
with
it,
and
I
you
know
I.
I
do
think
that
we'll
have
coco
19
in
our
lives
for
the
foreseeable
future.
D
I
I
do
think
that,
and
I
believe
that
we
can
find
ourselves
in
that
space
where
we
control
and
manage
the
spread
of
coca-19,
and
you
know
this
means
from
a
public
health
standpoint.
This
this
means
achieving
those
low
levels
of
transmission
and
sustaining
those
low
levels
of
transmission
over
long
periods
of
time
where
we
are
are
seeing
that
consistently
at
a
low
level
and
achieving
those
low
levels
of
spread.
D
You
know
it
means
that
we
we
have
to
protect
ourselves
and
our
community
and
one
of
the
best
ways
we
can
do
that
is
through
vaccination
and
the
more
that
we're
protected.
This
is,
you
know,
sort
of
the
corner.
D
You
know
some
of
the
foundational
work
of
what
public
health
is
about,
particularly
when
you
think
about
over
the
last
hundred
years
and
the
and
the
the
strides
that
have
been
made
around
infectious
disease,
the
more
we're
protected
as
a
people
and
as
a
community
that
extends
even
outside
of
our
county
lines,
the
less
we
allow
the
virus
to
infect
us
and
and
continue
to
control
our
lives
and
so
we're
at
this.
D
What
I
think,
I
believe
you
know,
I
think,
we're
at
this
really
pivotal
moment
right
now
that
we
can
achieve
a
place
where
we
control
and
manage
copa19,
where
we
you
know,
can
live
our
lives
with
this
virus
circulating
at
low
levels
and
that
we
begin
to
look
more
like
what
our
lives
did
before
covered
and
I,
like
I
said
in
the
last
few
weeks
to
me.
It
feels
like
a
very
big
pivotal,
a
very
pivotal
moment
that
our
vaccination
rates
are
increasing
right
now.
D
Our
children
are
most
of
our
children
are
now
eligible,
transmission
rates
are
declining,
and
so
I'm
hoping
and
I'm
you
know
hoping
as
we
approach
the
new
year
that
we
find
ourselves
in
a
space
where
we
are
controlling
this.
This
virus
and
controlling
this
illness
and
not
the
other
way
around,
and
that
that
continues
to
take
a
commitment
as
a
community
to
protect
ourselves
through
vaccination
and
possibly
layered
measure.
D
You
know
those
layered
protection
measures,
most
certainly
at
least
through
this
holiday
period,
while
we're
you
know,
still
experiencing
high
levels
of
transmission
and
spread,
and
just
now
getting
to
the
vaccination.
You
know
eligibility
for
our
pediatric
age
group,
and
so
you
know
I
I
hear
folks
when
I
when
they
say
can't.
We
just
live
with
this,
and
I
I
do
think
we'll
have
covert
around
for
a
long
time.
I
do
think
we'll
likely
get
to
a
place
where
it's
much
more
endemic,
and
we
are
approaching
that
I
believe.
D
But
in
order
to
get
to
that
space,
it
means
getting
it
to
lower
much
lower
levels
than
we
have
right
now
with
spread
and
transmission
so
that
we
are
controlling
and
managing
that
and
not
seeing
large
surges
of
cases
that
then,
you
know,
put
our
community
and
our
our
neighbors
and
families
and
friends
in
jeopardy
of
severe
illness,
hospitalization
and
then
the
worst
health
outcome
being
death.
B
When
I
hear
people
talk
about
and
the
comparison
of
coped
and
flu,
I
mean,
I
know
why
we
can
hear
it
they're,
both
viral
infections.
They
both
can
cause
mild,
moderate,
severe
disease.
They
both
we
can
infect
people
before
we
have
symptoms
and
we
don't
even
know
we're.
You
know
unknowing
we're
unknowingly
infecting
people.
B
B
So
I
think
that's
one
difference
in
points
there,
but
for
me
the
other
point
is
I
am
a
strong
believer
in
immunization,
for
a
flu
vaccine
also
and
vaccinations
with
flu
have
been
something
that
for
years
I
I
recommend
I
personally
take
my
children
take.
So
I
I
also
want
to
say
that
this
isn't
unique
to
covid
that
I
think
vaccination
is
an
important
way
to
stop
a
communicable
disease
they're
a
lot
out
there
and
I
think
that
vaccinations
on
the
whole
are
really
important.
C
And
megan,
can
I
say
something
to
that
too.
Yeah
thanks.
I
think
that
the
I
agree
with
everything
that's
been
said.
I
think
that
covet
isn't
the
flu.
I
think
it's
more
serious.
I
think
it's
like
the
flu.
I
think
that,
coming
up
into
this
winter,
we'll
see
more
transmission,
you'll
see
the
numbers
go
back
up,
we're
already
seeing
that
in
europe.
C
You
know
some
of
the
numbers
have
started
since
it's
getting
cold,
we've
started
seeing
some
of
the
numbers
in
europe
starting
to
climb
again
we
have
a
sustained
kind
of
infection
rate
right
now.
No,
it's
not
horrible,
but
it's
it's
there
and
I
think
that
it's
not
going
down.
So
I
do
think
that
we're
setting
ourselves
up
to
see
a
little
worsening.
C
You
know
maybe
a
grand
worsening
this
winter,
but
but
some
of
the
things
that
that
I
usually
consider,
especially
as
we
get
into
the
winter
months
and
and
and
with
the
covet
itself
is,
is
that
I
think
that
we
don't
need
to
be
personally
touched
with
a
bad
story
about
koget.
C
Now,
here
in
the
clinic,
I
I
hear
a
lot
of
bad
stories
about
covert
about
young
people
who
seem
to
get
really
nasty
versions
of
the
disease
without
any
comorbidities
or
without
anything
to
set
them
up
for
that,
and
it's
not,
unfortunately,
my
pediatric
population,
but
it's
definitely
in
families
and
and
grandparents
for
sure,
but
also
also
relatively
young
people,
40
50
60..
C
C
We
will
continue
to
see
smoldering
of
covid
for
probably
the
next
year
and-
and
this
is
a
captive
population,
a
population
of
kids
that
I
think
could
really
could
really
alter
the
course
of
covid
and
and
I'm
and
I'm
still
going
back
to
the
fact
that
I
really
believe
that
this
vaccine
is
a
good
vaccine,
it's
far
better
than
the
than
the
copa
disease,
but
it
also
helps
so
many
more
people,
and
I
think
that
we
can't
forget
that
that
I
think
it's
a
team
approach.
Yes,
it's
our
children.
C
A
And
I
will
say
that
it
seems
as
though
kids
have
an
intuitive
understanding
of
this,
because
I
mean
when
my
children
heard
that
they
were
going
to
be
eligible
to
get
the
vaccine.
They
were.
They
were
proud
and
excited,
and
you
know
which
is
really
strange
because
usually
that's
not
their
reaction
to
vaccines
at
all.
So
I
think
they
kind
of
understand
that
just
sort
of
the
largeness
of
this
pandemic
and
that
they
can
do
something
too,
which
is
nice
for
them
developmentally.
So,
okay.
A
So
if
we
were
wanting
to
get
our
kids
vaccinated
in
buncombe
county,
what
would
we
need
to
know
in
order
to
do
that?
Stacey.
D
Yeah,
I
think
I
can
start
and
then
welcome
others
to
to
chime
in
as
well
that,
just
like
with
adult
vaccine,
we
have
lots
of
vaccine
providers
in
buncombe
county
and
that
there
is
a
north
carolina
website
find
your
spot.
D
Some
of
our
fellow
qualified
health
centers
also
have
vaccine,
and
so
it's
really
important
to
think
about.
Where
is
the
space
that
you
want
to
get
your
child
vaccinated
because
they're
they
vary
like
like?
I
said
there
there's
opportunity
within
what
we
would
consider
sort
of
a
traditional
doctor's
office,
but
there's
also,
you
know
an
opportunity
for
access
at
your
grocery
store
or
local
pharmacy.
D
Just
down
the
street
from
you
or
at
one
of
our
community
events,
and
so
in
addition
to
so
the
health
department,
where
you
know
we
give
we're
able
to
administer
any
of
the
vaccines
that
are
available,
and
that
does
mean
for
adults
which
are
all
three
types
and
then
the
pediatric
doses
as
well.
D
We
started
administering
those
last
week,
as
did
lots
of
vaccine
providers,
so
you
can
visit
us
at
the
health
department
and
beginning
next
week,
we'll
be
administering
at
the
health
department,
tuesday,
through
friday,
from
nine
to
four,
but
also
next
week.
We
are
starting
our
outreach
into
the
community
as
well
and
building
on
the
success
that
we
had
with
our
school
partners
throughout
the
vaccine.
Rollout
and
we'll
be
moving
around
to
different
schools
every
week
and
we'll
start
on
november
13th
at
asheville
middle
school
9-4.
D
But
in
addition
to
that
and
then
every
week
we
move
to
a
different
school
and
those
are
listed
on
our
website
and
just
to
get
some
geographical
distribution.
We
want
to
make
sure
that
if
folks
are
wanting
to
get
their
child
vaccinated,
that
they
have
the
opportunity
to
do
so.
So
we'll
be
centrally
located
first
and
then
moving
out
into
other
geographical
areas
of
the
of
the
county
for
folks
and
even
though
those
are
are
going
to
be
located
on
public
school
campuses.
D
Anyone
in
the
community
is
is
welcome
to
come
because
we'll
have
not
just
pediatric
doses
but
other
doses
available
too,
and
what
I've
found
and
what
I,
what
I'll
be
doing
as
a
what
we
found
in
our
clinic
last
week,
is
that
when
folks
are
bringing
in
their
kiddo
for
their
vaccine
a
lot
of
times,
the
parent
or
caregiver
is
coming
in
for
their
booster
or
maybe
even
their
second
dose
or
their
booster.
D
So
looking
at
it
as
a
as
a
buddy
system,
almost
and
and
that's
exactly
what
I'll
be
doing
with
my
with
my
10
year
old
and
when
he
gets
his
vaccine
this
week.
But
in
addition
to
the
outreach
events
that
we're
going
to
be
hosting,
we
have
other
partners
who
are
also
doing
other
events,
including
the
north
carolina
department
of
health
and
human
services,
has
a
state
supported
site
which
is
going
to
be.
It
started
november
6th
and
it's
at
the
eddington
center.
D
On
livingston
street,
not
far
from
mission
hospital
and
they're,
providing
all
vaccine
types
as
well
with
a
focus
on
on
pediatrics,
and
then
our
partners
at
mayheck,
with
the
fema
resource,
also
have
we'll
also
be
doing
some
school
outreaches
in
december,
and
so
we
have
lots
of
opportunities
and,
as
I
said
you
know,
sometimes
the
easiest
thing
to
do
is
to
check
out
find
my
spot
website
put
in
your
zip
code
and
lots
of
options
will
come
up.
A
Okay,
so
we're
coming
really
close
to
the
end
of
our
time,
so
I
I
was
just
hoping
that
maybe
all
of
the
panelists
might
weigh
in
on
this
one.
If
listeners,
those
that
are
with
us
now
and
those
that
might
listen
to
this
later,
could
leave
here
with
only
one
piece
of
information.
What
would
you
want
it
to
be?
D
Sure
I
can
kick
us
off
with
that
one.
You
know-
and
I
think
I
mentioned
a
little
bit
earlier-
that
I
I
do
think
this
is
a
pivotal
moment.
We
have
an
opportunity
and
that's
pretty
exciting.
As
I
mentioned,
you
know
my
son's
getting
his
vaccine
this
week.
Our
whole
family
is
pretty
excited
about
that
once
he's
vaccinated.
That
means
that
you
know
everyone
in
my
family
will
be
fully
vaccinated
and
that
you
know
opens
a
lot
of
doors
for
us.
D
I
think,
and-
and
you
know
in
general,
the
pediatric
vaccine
eligibility
feels
like
a
really
big
moment
for
me
as
a
public
health
professional
but,
as
I
said
like
also
as
a
mom,
so
as
we're
getting
kiddos
vaccinated,
you
know,
while
we're
in
that
process.
D
One
thing
that
I
really
have
to
continue
to
remind
folks
or
feel
compelled
to
remind
folks
is
that
we're
still
in
a
time
of
you,
know,
high
transmission.
Those
cases
are
coming
down.
That's
really
exciting.
We
are
entering
the
holiday
time
period,
and
so
I
you
know,
I
just
want
to
remind
folks
that
as
we're
as
we're
in
this
exciting
time
of
vaccinating
5
to
11
year
olds
and
moving
into
our
holiday
season,
it's
rem.
It's
really
important
to
remember,
to
rely
on
other
measures,
those
layered
approaches
too.
D
While
we
continue
to
vaccinate
folks
like
our
face
coverings
and
keeping
distance
and
those
those
simple
steps,
really
do
they
do
matter,
and
so,
particularly
as
we're
you
know
seeing
high
rates
still
of
transmission.
B
So
megan
I'll
I'll
say
that
I
just
hope,
as
we,
if
somebody's
watching
this
later
somebody
who's
considering
having
their
child
vaccinated
that
it
I
I
hope
they
take
with
them
the
the
the
fantastic
brains
that
have
worked
on
this,
the
science
that
has
gone
for
the
ability
that
we
were
able
to
just
immediately
sequence,
this
virus
and
and
move
forward
with
something
that
really
can
change
this
course
and
so
for
our
children.
B
I
just
I
I
take
forward
that
that
that
science
and
just
having
those
trusted
advisors
that
you've
had
in
your
life
before
cova2,
whether
that's
your
pediatrician
or
family
practitioner
or
the
the
the
leaders
in
the
science
and
using
those
people
to
be
your
your
ability
to
work
through
some
of
your
fears
and
some
of
your
questions
with
them.
I
think
that's
just
a
great
thing
that
we
have
access
to
that.
E
I'll
go
next,
so
I
don't
have
to
go
last
and
just
say
you
know
that
I
think,
like
I
said
earlier,
you
know
all
of
us
are
really
ready
to
be
back
to
something
closer
to
normal.
You
know
more
on
the
other
side
of
this.
I
think
vaccination
is
a
great
way
for
us
to
get
there.
We
know
these
vaccines
are
safe
and
effective.
So
you
know,
like
dr
wade,
said
you
know,
for
anyone
that
has
questions.
E
C
And
I
can
say
a
couple
things
I
just
think.
I
think
one
piece
of
information
I
think
you
should
know
is
that
is
that
it
says
for
me,
you
know,
like
I'm
not
paid
to
get
vaccines,
give
vaccines.
My
kids
I
had
to.
I
have
a
12
or
10
a
12
and
a
14
year
old
and
and-
and
I
think
that
I
want
it's
a
wonderful
time-
we
can
involve
children
in
this
decision
process.
We
can.
C
We
can
enforce,
altruism
and
thinking
about
our
peers
and
other
people
that
we
care
for
teachers,
grandparents,
but
I
also
think
that
it's
nice
to
educate
kids
on
on
how
public
health
works,
how
these
vaccines
work
and
I'm
optimistic
that
that
that
knowledge
and
and
the
and
obviously
the
science
and
it's
a
wonderful
time
to
exist
and
to
to
teach
about
this,
and
so
as
a
pediatrician
I
get
to
teach
about
it
in
the
room
every
day.
C
I
encourage
people
to
talk
about
their
about
their
concerns
with
their
docs
most
of
the
time,
that's
behind
a
closed
door
and-
and
I
like
talking
about
it-
I
like
talking
to
people
in
a
room
about
about
covert
vaccine
vaccinations,
why
I
chose
to
do
it
for
my
children
and-
and
I
think
we
all
have
to
come
to
our
own
sort
of
personal
algorithm,
a
a
a
a
way
of
weighing
the
pros
and
negat
the
pros
and
the
cons,
and
I'm
excited
to
be
at
this
point
where
we
can
actually
affect
change.
A
All
right
well,
thank
you
all
so
much
for
your
attendance
tonight.
Thank
you
to
the
panelists
who
have
extended
your
work
days.
I
think
most
of
you
probably
talked
about
covet
all
day
at
work
and
then
talked
about
covets
more
after
work.
A
So
I
personally
appreciate
that
very
much
and
I
want
to
make
an
announcement
that
there
is
a
link
to
the
conversation
here
that
will
be
available
on
the
buncombe
county
facebook
page
after
we
conclude
and
if
you
just
can't
get
enough
of
this
information,
there's
also
a
fireside
chat
today
at
6
30,
so
in
three
minutes
on
the
on
the
north
carolina
dhhs
website,
and
that
is
featuring,
mandy
cohen
and
dr
rashida
monroe
and
it's
facilitated
by
molly
grantham.